Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (10008)	10/25/2008 10:27:18 AM
From: fred hayes	Read Replies (1) \| Respond to of 10345

Tom, the best board is IV at investorvillage.com But the quality of the posts is pretty low. I patrol it occasionally, but I would recommend the Irish brokers for the best coverage. Start here. rte.ie Hope you don't give up too soon. I still think the BAP P3 may yield an AZ drug. And I think that T will be okay. It's hard for it not to be okay since it is by far the most effective MS drug out there, IMO. I think folks on the other stuff will steadily be switching unless we get a really big PML problem, which is possible but I don't think very likely. Drug delivery royalties should be growing nicely, and they fall right to the bottom line. And they could pull a rabbit out of the hat on Parkinsons, with a little luck. I think these are very smart people, at least the science types.